No Data
Investors in MeiraGTx Holdings (NASDAQ:MGTX) Have Unfortunately Lost 71% Over the Last Five Years
Express News | MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (Rmat) Designation for Aav2-Haqp1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
Is MeiraGTx Holdings (NASDAQ:MGTX) Using Too Much Debt?
MeiraGTx Holdings Plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know
MeiraGTx Holdings Reports Significant Losses Amid Strategic Moves